Michael A. Caligiuri

Michael A. Caligiuri, M.D., is the President of the City of Hope Natonal Medical Center and holds the Deana and Steve Campbell Physician-in-Chief Distinguished Chair. He is a world-renowned physician, scientist, builder, innovator, leader and visionary. Dr. Caligiuri is dedicated to developing the next generation of leading-edge immune therapies for cancer, rapidly delivering them to patients and ultimately curing the disease.

​

Prior to joining City of Hope, Dr. Caligiuri worked for 20 years as a physician, scientist and leader in the cancer program at The Ohio State University. He spent the past decade as CEO of The James Cancer Hospital and Solove Research Institute and directed The Ohio State University Comprehensive Cancer Center for 14 years, recruiting over 300 cancer physicians and scientists and building the 3rd largest cancer hospital in America.

​

Dr. Caligiuri has spent the last 35 years studying human natural killer (NK) cell biology during which time he made several seminal discoveries that have paved the way for CAR NK cells to advance into the clinic. He has over 400 peer-reviewed original research publications on NK cells and/or cancer. Over 1,000 patients have been treated on clinical trials designed or co-designed by Dr. Caligiuri to modulate NK cells for cancer therapy.

​

Dr. Caligiuri is the past president (2018) of the American Association for Cancer Research (AACR), the world’s largest cancer research organization with 40,000 members in 120 countries. He was elected as a Fellow to the AACR Academy, received a lifetime achievement award from Stanford University School of Medicine and was elected to the US National Academy of Medicine for his basic and translational work on human NK cells and cancer.